Glucose-albumin ratio as new biomarker for predicting mortality after intracerebral hemorrhage
Neurosurgical Review · 19.04.2023 · 46 (1)
DOI: 10.1007/s10143-023-02002-7 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Neurosurgical Review, online erschienen am 19.04.2023. Verfasst von Jialing He und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Second Affiliated Hospital of Guangzhou Medical University, No. 250, Changgang East Road, Guangzhou, 510260, Guangdon…. Hauptthemen laut MEDLINE: Glucose, Cerebral Hemorrhage. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: This study aims to evaluate the prognostic value of blood-based biomarkers and their combinations, in particular the glucose-albumin ratio (GAR), in patients with spontaneous intracerebral hemorrhage (ICH). METHODS: A retrospective observational study on 2481 patients from one hospital was conducted and validated with 602 patients from another. We assessed 15 biomarkers and focused on GAR to elucidate its prognostic and predictive value for outcomes in both cohorts. The primary outcome was mortality at 90 days. RESULTS: The ratio of glucose-to-albumin, defined as GAR, was superior to other biomarkers for predicting mortality at 90 days in patients with ICH (AUC = 0.72). High GAR (using the best cutoff value of 0.19) was associated with increased mortality at 90 days (odds ratios of 1.90, 95% CI 1.54-2.34) and all-cause mortality in the first 3 years after admission (hazard ratio of 1.62, 95% CI 1.42-1.86). All aforementioned findings for GAR were successfully validated in an external independent cohort. CONCLUSIONS: GAR may be a valuable biomarker for predicting the mortality of patients with ICH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The Second Affiliated Hospital of Guangzhou Medical University, No. 250, Changgang East Road, Guangzhou, 510260, Guangdong, China.
- Department of Neurosurgery, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
- Department of Neurosurgery, Longquan Hospital, Chengdu, Sichuan, China.
- Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, USA.
- Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
- Department of Critical Care Medicine, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
Zitieren
APA
He, J., Zhang, Y., Li, T., Deng, H., Wang, P., Chong, W., Hai, Y., Chen, L., You, C., Jia, L., Wang, Y., & Fang, F. (2023). Glucose-albumin ratio as new biomarker for predicting mortality after intracerebral hemorrhage. Neurosurgical Review, 46(1). https://doi.org/10.1007/s10143-023-02002-7
Vancouver
He J, Zhang Y, Li T, Deng H, Wang P, Chong W, et al. Glucose-albumin ratio as new biomarker for predicting mortality after intracerebral hemorrhage. Neurosurgical Review. 2023;46(1). doi:10.1007/s10143-023-02002-7
BibTeX
@article{He2023,
author = {He, Jialing and Zhang, Yu and Li, Tiangui and Deng, Haidong and Wang, Peng and Chong, Weelic and Hai, Yang and Chen, Lvlin and You, Chao and Jia, Lu and Wang, Yezhong and Fang, Fang},
title = {Glucose-albumin ratio as new biomarker for predicting mortality after intracerebral hemorrhage},
journal = {Neurosurgical Review},
year = {2023},
volume = {46},
number = {1},
doi = {10.1007/s10143-023-02002-7}
}
EUVIMED